Bilcare Ltd
BSE:526853
Bilcare Ltd
BSE:526853
Price:
64.39 INR
0.16%
Market Closed
Updated:
May 2, 2024
Bilcare Ltd
Operating Income
|
Bilcare Ltd
Operating Income Peer Comparison
Comparables:
DIVISLAB
SUVEN
DCAL
SYNGENE
I
INNOVACAP
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bilcare Ltd
BSE:526853
|
Operating Income
₹208.8m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-11%
|
|
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
Operating Income
₹20.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Suven Life Sciences Ltd
NSE:SUVEN
|
Operating Income
-₹1.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dishman Carbogen Amcis Ltd
NSE:DCAL
|
Operating Income
-₹141.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Syngene International Ltd
NSE:SYNGENE
|
Operating Income
₹6.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
I
|
Innova Captab Ltd
NSE:INNOVACAP
|
Operating Income
₹958.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bilcare Ltd's Operating Income?
Operating Income
208.8m
INR
208.8m
INR
Based on the financial report for Dec 31, 2023, Bilcare Ltd's Operating Income amounts to 208.8m INR.
What is Bilcare Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-11%
-11%
Over the last year, the Operating Income growth was -10%. The average annual Operating Income growth rates for Bilcare Ltd have been -46% over the past three years , and -11% over the past ten years .
You don't have any saved screeners yet
